Meningitis Cases Prompt Action in Ille-et-Vilaine, France

Health officials in Ille-et-Vilaine, a department in the Brittany region of France, are responding to a recent ⁣increase in meningococcal meningitis cases. The regional ⁢Health⁢ Agency (ARS) is actively working to identify⁢ and manage ‍potential contacts⁢ of those infected.

Two adolescents,ages 16 and 19,were hospitalized‍ in intensive care units at the Rennes University Hospital this ⁤week after contracting meningococcal B⁣ meningitis,the ARS confirmed in a‍ press release. The news was initially reported by Ouest-France.

ARS teams are “working to identify⁤ contacts ‍in order ‍to take all necessary measures,” according to ⁢the agency. The National ⁣Reference⁤ Center ‍of the Pasteur Institute⁢ will conduct sequencing of the strains from ⁣these two cases of invasive meningococcal infections of serogroup B.

These recent cases follow earlier ⁢incidents in Ille-et-Vilaine. ⁢In February, an 18-year-old teenager ‍died in Rennes. Later, on March 1, the ARS of Brittany announced a large-scale vaccination campaign targeting 100,000 young people aged 15 to 24 in⁣ the Rennes Métropole area. As ‍of Wednesday, the ARS stated that “64,152 people have received at least one dose of vaccine.”

Across France, health ‍authorities have observed an increase in invasive infections in Meningococci (IIM), including those linked to serogroup B, during the 2024-2025 season, “with a particularly high number of cases in January,” the ARS noted.⁣ The Rennes metropolis, with nearly half a million residents, is “particularly concerned by this situation.”

Expanded Vaccination Efforts

Since December, the ARS of Brittany has been “intervening around several situations of invasive infections with⁣ type ⁤B meningococcal in Ille-et-vilaine, in particular by‍ taking charge of the cases detected and the contacts,” including responses to cases detected in a Rennes business school and within a family.

The ministry of Health announced on April 24 that vaccination against meningococci, already expanded nationally since⁣ January, will be further broadened in response to the outbreak of meningitis cases and other ⁤infections caused by⁢ these bacteria. Public⁤ Health France reports that more ‍than 600 cases of meningococcal infections⁤ have been identified since the beginning⁣ of the year, marking an unprecedented level since 2010.

The increase in cases has been evident for several years, prompting health authorities to expand vaccination efforts to address the rise of new strains: A, Y, and W, with the‍ latter being particularly deadly.These strains have largely supplanted meningococcus C, which was previously the primary target ⁣of vaccination⁣ efforts. However, strain B remains the most prevalent.

#⁣ Meningitis in Ille-et-Vilaine, France: Yoru Questions Answered

Are ⁢you concerned about‍ the recent meningitis cases in Ille-et-Vilaine,‍ France? This article ⁣provides answers to your most pressing questions, based on the latest data from health ‍authorities.

## What’s happening with meningitis in Ille-et-Vilaine?

Health officials in Ille-et-Vilaine, a department in the Brittany region of France, are responding to a recent increase in meningococcal meningitis cases. The regional Health Agency (ARS) is ‍actively working to identify and manage potential contacts ⁣of ‍those infected.

##⁣ Who ‍is⁢ affected?

Two adolescents, aged 16 and 19, were hospitalized in intensive care units⁤ at the Rennes ⁤University ⁢Hospital after contracting meningococcal B meningitis. ‍In february, an 18-year-old teenager died in Rennes due‍ to ⁢the disease.

## What type of⁢ meningitis is prevalent?

According to the information, the recent cases involve meningococcal B meningitis.

## What is the ARS doing in response?

The ARS ⁤is:

* ⁣ ⁢ Identifying ⁤and managing contacts of infected individuals.

* Conducting sequencing of the‍ strains with the National Reference Center of the Pasteur ‍Institute.

* ⁣ Implementing and expanding vaccination campaigns.

## What is the role of the Pasteur Institute?

The national reference ⁢Center of the Pasteur Institute will conduct sequencing of the strains from the recent cases to understand the specific type of meningococcal infections.

## ‍What vaccination efforts⁣ are underway?

A large-scale vaccination ⁣campaign was announced on March ⁢1,targeting 100,000 young people aged⁤ 15 to 24 in the Rennes Métropole area. As of Wednesday (the ⁢article’s publishing date), 64,152 people had received at least one dose of the vaccine.The ministry of Health announced on⁢ April 24 that vaccination against meningococci‍ will be further broadened.

## Why are vaccinations being expanded?

vaccination efforts are being expanded ⁤in response to the increase⁣ in meningitis cases and other infections caused by these bacteria. Authorities have observed a rise ‍in ⁤invasive infections in Meningococci (IIM), including those linked to serogroup ⁣B. Public Health France reports that more than 600 cases of meningococcal infections have been identified ‍as the‍ beginning of the year, marking an unprecedented level sence 2010.

## Where are these cases most concentrated?

The Rennes metropolis, with nearly half a⁣ million residents, is “especially concerned‍ by this situation.”

## Wich strains of ⁤Meningococci are concerning?

The increase in cases⁢ has been evident for ⁢several years, ⁣prompting⁤ health authorities to expand vaccination efforts to‍ address the rise of‍ new strains: A, Y, and⁣ W, with the latter being particularly deadly.Strain⁤ B remains the most prevalent.

## What ⁢does “meningococcal” mean?

Meningococcal refers to ⁢bacteria of the ⁢species *Neisseria meningitidis*, which can cause ⁣serious infections, including meningitis and septicemia.Meningitis is an inflammation ‍of the membranes surrounding the brain and spinal cord.

## ‍How‍ many cases have there been recently?

Public Health France reports that more than 600 cases‍ of meningococcal infections have been⁤ identified since the beginning of the year.

## When did this increase begin?

The increase in cases has been evident for several years, according to the⁢ information in the article.

## What is the overall situation with vaccination in⁤ France?

Vaccination against meningococci was already expanded nationally ⁢since January.

## What⁢ are the key⁣ differences among the Meningococcal⁢ strains?

Here’s a ⁣summary of the different Meningococcal strains:

Strain	Key Characteristics	Prevalence
B	Most prevalent	Currently⁣ dominant
A, Y, W	Expanded vaccination efforts target these	Increasing in prevalence
C	Previously primary vaccination target	Largely supplanted by⁣ newer strains